Clinical Trial Update: Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating Erlotinib or Crizotinib in combination with chemoradiation for Stage III non-small cell lung cancer; study terminated with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Crizotinib (crizotinib)
• Erlotinib hydrochloride (Erlotinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage III Non-Small Cell Lung Cancer AJCC v7, Stage IIIA Non-Small Cell Lung Cancer AJCC v7 | Phase 2 | Status: TERMINATED | Results posted: 2019-08-05